Dr. Page was formerly a Professor in Residence in the Department of Epidemiology and Biostatistics, Division of Infectious Disease, in the Department of Medicine at University of California San Francisco (UCSF). She is now Professor and Chief of Epidemiology, Biostatistics & Preventive Medicine at the University of New Mexico. She received her Ph.D and MPH from the University of California at Berkeley and completed fellowships at the UCSF Center for AIDS Prevention Studies and the Municipal Health Service in Amsterdam, the Netherlands. She has been the PI of multiple NIH and CDC funded grants, and collaborates with researchers nationally and internationally. Dr. Page is an infectious disease epidemiologist; her research is principally focused on HIV and hepatitis C virus (HCV) infections, principally prevention, natural history, and intervention research in marginalized and underserved populations including injection drug users, and female sex workers. She is currently leading a clinical trial testing a prophylactic HCV vaccine in active injection drug users and a large implementation science trial in Cambodia to reduce drug use and HIV infection in female sex workers. She is the PI of two NIH NIDA funded studies of of HIV and HCV including: the UFO Study, an internationally recognized study of acute HCV in young adult injection drug users, and, the InC3 Collaborative, which brings together investigators and data from preeminent prospective studies of HIV and HCV globally. Dr. Page has been a faculty lead, as Director of Latin and Central America Region for the Fogarty funded International Traineeships in AIDS Prevention Studies (ITAPS) program at UCSF since 2002, providing training and capacity building to scientists from developing countries including Brazil, Argentina, Peru, Guatemala, Mexico, and from Southeast Asia, including Cambodia and Thailand. To learn more about Dr. Page please visit the links below.
User Profile Bio
